Growing community of inventors

Brookline, MA, United States of America

Shivang Doshi

Average Co-Inventor Count = 3.87

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 12

Shivang DoshiYan Chen (2 patents)Shivang DoshiChristopher Thomas Brain (16 patents)Shivang DoshiSunkyu Kim (4 patents)Shivang DoshiKristy Haas (2 patents)Shivang DoshiSteven Kovats (2 patents)Shivang DoshiAlan Xizhong Huang (2 patents)Shivang DoshiGiordano Caponigro (1 patent)Shivang DoshiThomas Horn-Spirohn (1 patent)Shivang DoshiScott Delach (1 patent)Shivang DoshiJianguo Ma (0 patent)Shivang DoshiMaria Borland (0 patent)Shivang DoshiHong Zhang (0 patent)Shivang DoshiJosh Murtie (0 patent)Shivang DoshiShivang Doshi (4 patents)Yan ChenYan Chen (50 patents)Christopher Thomas BrainChristopher Thomas Brain (16 patents)Sunkyu KimSunkyu Kim (6 patents)Kristy HaasKristy Haas (2 patents)Steven KovatsSteven Kovats (2 patents)Alan Xizhong HuangAlan Xizhong Huang (2 patents)Giordano CaponigroGiordano Caponigro (13 patents)Thomas Horn-SpirohnThomas Horn-Spirohn (3 patents)Scott DelachScott Delach (3 patents)Jianguo MaJianguo Ma (0 patent)Maria BorlandMaria Borland (0 patent)Hong ZhangHong Zhang (0 patent)Josh MurtieJosh Murtie (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (4 from 3,923 patents)


4 patents:

1. 10010552 - Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer

2. 9867825 - Pharmaceutical combination comprising binimetinib

3. 9408847 - Combination therapy

4. 9271988 - Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…